NEW HAVEN, Conn., June 08, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has launched the HemeScreen® Anemia Panel as part of its suite of ...

An FDA advisory committee almost unanimously agreed that the risks were just too high for the chronic kidney disease (CKD)-related anemia drug roxadustat in any patient population. In a 13-1 vote ...

The Food and Drug Administration said Friday that it will form a panel to address safety concerns surrounding anemia drugs made by Amgen Inc. and Johnson & Johnson. The panel is set to meet September ...

Faced with a variety of new studies that suggest that blockbuster anemia drugs raise the risk of death or make patients' cancer worse, an FDA advisory panel has voted to restrict the use of the drugs, ...

Hemotransfusion in treatment of anemia, 3D illustration showing two populations of red blood cells, small hypochromic red blood cells and normal. A small lymphocyte is drawn for size comparison The ...

Management of CML in community setting: Basis for a quality initiative. This is an ASCO Meeting Abstract from the 2025 ASCO Quality Care Symposium. This abstract does not include a full text component ...

A Food and Drug Administration advisory panel said Thursday that anti-anemia drugs by Amgen Inc. and Johnson & Johnson should continue to be marketed to cancer patients despite concerns the drugs ...

Concerns over thromboembolic events and MACE risk were discussed during the meeting. The Food and Drug Administration (FDA)’s Cardiovascular and Renal Drugs Advisory Committee (CRDAC) voted 13 to 1 ...